Navigation Links
Mass. Eye and Ear announces Curing Kids Fund grant recipients
Date:5/15/2012

Boston (May 15, 2012) The Mass. Eye and Ear Curing Kids fund has awarded grants for research projects that aim to help the brain locate sound, identify genes that cause congenital blindness, cure deafness through hair cell regeneration, and improve treatment for childhood eye cancer. The 2011/2012 Curing Kids Fund grants were made possible by funds raised from the hospital's annual Sense-sation! gala.

This year's grant recipients are:

  • Bertrand Delgutte, Ph.D. (Mass. Eye and Ear Eaton-Peabody Lab/MIT Research Lab of Electronics) -- "Restoring Binaural Hearing with Cochlear Implants in Early-Onset Deafness," which will study ways that perceptual training can help the brain to locate sounds in subjects with early-onset deafness. Results will eventually lead to new sound processors and rehabilitation strategies for people with bilateral cochlear implants.

  • Eric Pierce, M.D., Ph.D. (Mass. Eye and Ear Ocular Genomics Institute/Berman-Gund Laboratory) --"Disease Gene Discovery for Leber Congenital Amaurosis," seeks to identify new disease genes responsible for Leber Congenital Amaurosis as a step toward developing gene therapies for the disorder, which is an important cause of blindness in children.

  • Fuxin Shi, Ph.D. (Mass. Eye and Ear Eaton-Peabody Lab) -- "Exploiting the Wnt Signaling Pathway for Curing Deafness in Children," which will test the feasibility of curing deafness in children via regeneration of functioning hair cells.

  • Dong Feng Chen, M.D., Ph.D. (Schepens Eye Research Institute) -- "Epigenetic Regulation of Congenital Retinal Dystrophy," which will study gene regulation to reverse vision loss caused by inherited retinal diseases that are the most common cause of childhood blindness.

  • Bruce R. Ksander, Ph.D. (Schepens Eye Research Institute) -- "A New Treatment to Prevent the Development of Drug Resistant Cancer Stem Cells in Retinoblastoma," which will investigate treatment of possible drug-resistant and tumor-initiating cancer stem cells in retinoblastoma, a common eye cancer in children.

The Curing Kids fund was created in 2010 to help bring life-changing treatments to children and to accelerate cures and innovations through research. The 2011 Sense-ation! gala raised more than $1.2 million for the Mass. Eye and Ear Curing Kids Fund. Curing Kids Fund research grants are competitive grants awarded to Mass. Eye and Ear and Schepens Eye Research Institute investigators.

The five grants awarded are just one aspect of the Curing Kids Fund. Monies from the fund will also provide services for needy children such as eyeglasses and hearing aids, support core research, and seed a Curing Kids endowment for research to help children.


'/>"/>

Contact: Vannessa Carrington
vannessa_carrington@meei.harvard.edu
617-573-3341
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Related biology news :

1. BGI, GMU, Mass. Eye and Ear and OUHSC announce agreement to sequence 100 human adenoviruses
2. Mass. Eye and Ear awarded largest NIH grant in hospital’s history
3. Mass. General researchers develop functional, transplantable rat liver grafts
4. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
5. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
6. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
9. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
10. ChromaDex® Announces Financial Results for the Year Ended 2011
11. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader ... that uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in ... and safety of employees returning to the workplace. , “Some of the best ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... and medical screening, announces the launch of a testing service aimed at ... The new service is provided by ClearStar’s Medical Information Services (“MIS”) business ...
(Date:5/15/2020)... ... May 15, 2020 , ... The National Institutes of Health (NIH) ... based in Frederick, Maryland and Tysons Corner, Virginia, to provide patent legal services under ... another in the field of chemistry. The firm is one of nine firms in ...
Breaking Biology News(10 mins):
(Date:5/26/2020)... ... , ... Brilliant , the leading smart home control and lighting company, ... a new integration to bring more convenience, simplicity, and security to the smart home ... can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Simon Prakash, who will serve as the company’s executive vice president of product ... when Exo is disrupting the medical imaging space, bringing more than 24 years ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing ... Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, a role ... CEO Brian Miller and Sentien’s management team. , Mr. Ganz has more ...
(Date:5/14/2020)... ... May 13, 2020 , ... ... phenotypic readouts, providing little or no information on the drug’s mechanism of action ... characterization of compounds by measuring the activity of molecular pathways. This information can ...
Breaking Biology Technology: